Sun Pharma Share Price Live Updates: Sun Pharma's six-month beta highlights consistent performance

More in Finance

• Nuvama Wealth share price: Brokerage stock up over 6% today, just 5% away from peak on strong Q2 results | Check target

  Strong quarterly earnings driven by broad-based operational gains across major business divisions propelled the financial firm's market value toward record territory. A rapid expansion in client assets alongside enhanced operational efficiencies helped bolster investor sentiment. The sustained momentum also prompted analysts to reaffirm their positive outlook with an upgraded price target.

  4 min read
• How are ITC shares performing after Gold Flake Regular price hike by ₹10 per pack? Should you buy stock? Experts views

  The consumer goods giant implemented its second price revision of 2026 on its flagship cigarette brand to preserve profit margins and counter tax headwinds. This strategic pricing safeguards the company's most critical earnings driver, which generates over 30% of its tobacco sales volumes. Meanwhile, steady expansion across non-cigarette sectors like FMCG and hospitality continues to bolster the firm's broader financial stability.

  3 min read
• Australia stocks lower at close of trade; S&P/ASX 200 down 0.07%

  Trading concluded with a modest downturn across the domestic equity market as major indices lost ground by the final bell. Investors navigated a muted session that left benchmark measures slightly in negative territory. The modest decline reflects cautious positioning among market participants during the trading day.

  1 min read